Mini Review

Published on 25 Mar 2024

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

in Cardiovascular Metabolism

Yue Zeng
Yilang Li
Wenyue Jiang
Ning Hou

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1375400

2,906 views
1 citation

Review

Published on 11 Mar 2024

Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases

in Cardiovascular Metabolism

Jia Wang
Wei Guo
Qiang Wang
Yongjian Yang
Xiongshan Sun

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1364604

2,167 views

Brief Research Report

Published on 06 Mar 2024

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health

in Cardiovascular Metabolism

Eva Harlacher
Corinna Schulte
Sonja Vondenhoff
Philippe Schmitt-Kopplin
Philippe Diederich
Christian Hemmers
Julia Moellmann
Julia Wollenhaupt
Rogier Veltrop
Erik Biessen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1346475

2,003 views

Editorial

Published on 27 Feb 2024

Editorial: The interplay between oxidative stress, immune cells and inflammation in cardiovascular diseases

in Cardiovascular Metabolism

R. Nosalski
M. Siedlinski
K. B. Neves
C. Monaco

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1385809

1,291 views

Original Research

Published on 26 Feb 2024

Association of systemic inﬂammation response index with all-cause mortality as well as cardiovascular mortality in patients with chronic kidney disease

in Cardiovascular Metabolism

Lu Wei
Shiqing Mao
Xianhong Liu
Chuanqi Zhu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363949

1,946 views
2 citations

Clinical Trial

Published on 21 Feb 2024

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

in Cardiovascular Metabolism

Lucas Lage Marinho
Fabiana Hanna Rached
Aleksandra Tiemi Morikawa
Thauany Martins Tavoni
Ana Paula Toniello Cardoso
Roberto Vitor Almeida Torres
Antonildes Nascimento Assuncao
Carlos Vicente Serrano
Cesar Higa Nomura
Raul Cavalcante Maranhão

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1342832

1,754 views

Original Research

Published on 20 Feb 2024

Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease

in Cardiovascular Metabolism

Mengjiao Zhang
Jiechao Niu
Mengmeng Xu
Erhu Wei
Peng Liu
Guangyao Sheng

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367108

2,148 views

Review

Published on 05 Feb 2024

So close, yet so far away: the relationship between MAM and cardiac disease

in Cardiovascular Metabolism

Bo Lu
Xiaozhe Chen
Yulong Ma
Mingtai Gui
Lei Yao
Jianhua Li
Mingzhu Wang
Xunjie Zhou
Deyu Fu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1353533

2,777 views
2 citations

Original Research

Published on 08 Jan 2024

Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice

in Cardiovascular Metabolism

Niklas Dörmann
Elke Hammer
Karlotta Struckmann
Julia Rüdebusch
Kirsten Bartels
Kristin Wenzel
Julia Schulz
Stefan Gross
Stefan Schwanz
Elisa Martin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1323760

2,450 views

Editorial

Published on 21 Dec 2023

Editorial: Cardiac energetic efficiency and cardiometabolic diseases

in Cardiovascular Metabolism

Teresa Vanessa Fiorentino
Francesca Cinti
Ram Jagannathan

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1352798

1,264 views

Systematic Review

Published on 06 Dec 2023

The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy

in Cardiovascular Metabolism

Sha Su
Xiang Ji
Tong Li
Yu Teng
Baofu Wang
Xiaowan Han
Mingjing Zhao

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1291450

2,942 views
1 citation

Original Research

Published on 29 Nov 2023

Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes

in Cardiovascular Metabolism

K. Alluri
B. Srinivas
S. Belmadani
K. Matrougui

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1222243

1,690 views
2 citations

Editorial

Published on 13 Oct 2023

Editorial: COVID-19 mechanisms on cardio-vascular dysfunction: from membrane receptors to immune response, volume II

in Cardiovascular Metabolism

Ana Iochabel Soares Moretti
Roberto Schreiber
Amarylis B. A. Wanschel

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1278067

1,140 views

Original Research

Published on 06 Oct 2023

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A

in Cardiovascular Metabolism

Julius R. Herting
Jule H. König
Katarina Hadova
Alexander Heinick
Frank U. Müller
Paul Pauls
Matthias D. Seidl
Carolina Soppa
Uwe Kirchhefer

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1239555

2,531 views
1 citation

Editorial

Published on 05 Oct 2023

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases

in Cardiovascular Metabolism

Yuliang Liu
Yingying Guo
Pengyong Li
Haipeng Guo
Man Xu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1296935

1,827 views

Original Research

Published on 07 Sep 2023

Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases

in Cardiovascular Metabolism

Joanna Sulicka-Grodzicka
Piotr Szczepaniak
Ewelina Jozefczuk
Karol Urbanski
Mateusz Siedlinski
Łukasz Niewiara
Bartłomiej Guzik
Grzegorz Filip
Bogusław Kapelak
Karol Wierzbicki

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2023.1230051

1,927 views
2 citations

Navigation group

Articles

Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy

Recent advances of myotubularin-related (MTMR) protein family in cardiovascular diseases

Increased levels of a mycophenolic acid metabolite in patients with kidney failure negatively affect cardiomyocyte health

Editorial: The interplay between oxidative stress, immune cells and inflammation in cardiovascular diseases

Association of systemic inﬂammation response index with all-cause mortality as well as cardiovascular mortality in patients with chronic kidney disease

Safety and possible anti-inflammatory effect of paclitaxel associated with LDL-like nanoparticles (LDE) in patients with chronic coronary artery disease: a double-blind, placebo-controlled pilot study

Interplay between mitochondrial dysfunction and lysosomal storage: challenges in genetic metabolic muscle diseases with a focus on infantile onset Pompe disease

So close, yet so far away: the relationship between MAM and cardiac disease

Metabolic remodeling in cardiac hypertrophy and heart failure with reduced ejection fraction occurs independent of transcription factor EB in mice

Editorial: Cardiac energetic efficiency and cardiometabolic diseases

The changes of cardiac energy metabolism with sodium-glucose transporter 2 inhibitor therapy

Plasmacytoid dendritic cells contribute to vascular endothelial dysfunction in type 2 diabetes

Editorial: COVID-19 mechanisms on cardio-vascular dysfunction: from membrane receptors to immune response, volume II

Hypercontractile cardiac phenotype in mice overexpressing the regulatory subunit PR72 of protein phosphatase 2A

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases

Systemic and local vascular inflammation and arterial reactive oxygen species generation in patients with advanced cardiovascular diseases